(Q35214545)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12962514%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

review article

1 reference

title

Therapy for chronic obstructive pulmonary disease in the 21st century (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12962514%20AND%20SRC:MED&resulttype=core&format=json

chronic obstructive pulmonary disease

7 November 2019

main subject

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12962514%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Duncan F Rogers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12962514%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

publication date

1 January 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12962514%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12962514%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12962514%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12962514%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

page(s)

1973-1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12962514%20AND%20SRC:MED&resulttype=core&format=json

c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis

7 November 2019

cites work

1 reference

12 December 2020

Prostaglandin H synthase 2 expression in airway cells from patients with asthma and chronic obstructive pulmonary disease

1 reference

12 December 2020

Requirement of the IFN-alpha/beta-induced CXCR3 chemokine signalling for CD8+ T cell activation

1 reference

12 December 2020

Neutrophil elastase: path clearer, pathogen killer, or just pathologic?

1 reference

12 December 2020

Protective effect of spin trap agent, N-tert-butyl-alpha-phenylnitrone on hyperoxia-induced oxidative stress and its potential as a nitric oxide donor

1 reference

12 December 2020

Chronic obstructive pulmonary disease is associated with the -1055 IL-13 promoter polymorphism

1 reference

12 December 2020

Nicotinamide N-oxides as CXCR2 antagonists

1 reference

12 December 2020

Late-term smoking cessation despite initial failure: an evaluation of bupropion sustained release, nicotine patch, combination therapy, and placebo

1 reference

12 December 2020

Pharmacodynamic steady state of tiotropium in patients with chronic obstructive pulmonary disease

1 reference

12 December 2020

IFN-gamma-inducible T cell alpha chemoattractant is a potent stimulator of normal human blood T lymphocyte transendothelial migration: differential regulation by IFN-gamma and TNF-alpha

1 reference

12 December 2020

Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease

1 reference

12 December 2020

Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium

1 reference

12 December 2020

Hypoestoxide, a novel anti-inflammatory natural diterpene, inhibits the activity of IkappaB kinase

1 reference

12 December 2020

Effectiveness of fluticasone propionate and salmeterol combination delivered via the Diskus device in the treatment of chronic obstructive pulmonary disease

1 reference

12 December 2020

Smoking cessation: the role of bupropion among new pharmacologic agents

1 reference

12 December 2020

Long-acting beta2-agonists for chronic obstructive pulmonary disease

1 reference

12 December 2020

Synthesis and biological characterization of L-N(6)-(1-iminoethyl)lysine 5-tetrazole-amide, a prodrug of a selective iNOS inhibitor

1 reference

12 December 2020

Airway nerves: neurotransmitter release.

1 reference

12 December 2020

Anti-inflammatory cytokines in asthma and allergy: interleukin-10, interleukin-12, interferon-gamma

1 reference

12 December 2020

Effect of a matrix metalloproteinase inhibitor (ONO-4817) on lung metastasis of murine renal cell carcinoma.

1 reference

12 December 2020

Anti-inflammatory effects of a p38 mitogen-activated protein kinase inhibitor during human endotoxemia

1 reference

12 December 2020

Clonidine for smoking cessation.

1 reference

12 December 2020

Safety and efficacy of disease-modifying anti-rheumatic agents: focus on the benefits and risks of etanercept

1 reference

12 December 2020

Joint damage and inflammation in c-Jun N-terminal kinase 2 knockout mice with passive murine collagen-induced arthritis

1 reference

12 December 2020

The JNK signal transduction pathway

1 reference

12 December 2020

A molecular mechanism of action of theophylline: Induction of histone deacetylase activity to decrease inflammatory gene expression.

1 reference

12 December 2020

Management of influenza in patients with asthma or chronic obstructive pulmonary disease

1 reference

12 December 2020

Modulation of leukotriene B4 receptor-1 expression by dexamethasone: potential mechanism for enhanced neutrophil survival

1 reference

12 December 2020

First Siena International Conference on animal models of chronic obstructive pulmonary disease, Certosa di Pontignano, University of Siena, Italy, September 30-October 2, 2001

1 reference

12 December 2020

Radioprotection of lung and esophagus by overexpression of the human manganese superoxide dismutase transgene.

1 reference

12 December 2020

Reduction of in vivo tumor growth by MMI-166, a selective matrix metalloproteinase inhibitor, through inhibition of tumor angiogenesis in squamous cell carcinoma cell lines of head and neck

1 reference

12 December 2020

Ongoing trials with matrix metalloproteinase inhibitors

1 reference

12 December 2020

The economic burden of COPD.

1 reference

12 December 2020

Cigarette smoking reduces histone deacetylase 2 expression, enhances cytokine expression, and inhibits glucocorticoid actions in alveolar macrophages

1 reference

12 December 2020

Extracellular signal-regulated kinase 1/extracellular signal-regulated kinase 2 mitogen-activated protein kinase signaling and activation of activator protein 1 and nuclear factor kappaB transcription factors play central roles in interleukin-8 expr

1 reference

12 December 2020

Neutrophil-derived elastases and their inhibitors: potential role in the pathogenesis of lung disease

1 reference

12 December 2020

Synthesis and structure-activity relationship of 2-amino-3-heteroaryl-quinoxalines as non-peptide, small-molecule antagonists for interleukin-8 receptor

1 reference

12 December 2020

Anxiolytics for smoking cessation

1 reference

12 December 2020

Biologic therapy of inflammatory bowel disease.

1 reference

12 December 2020

From mucolytic to antioxidant and liver protection: new aspects in the intensive care unit career of N-acetylcysteine

1 reference

12 December 2020

The effect of augmentation therapy on bronchial inflammation in alpha1-antitrypsin deficiency

1 reference

12 December 2020

Pulmonary alveolus formation: critical period, retinoid regulation and plasticity.

1 reference

12 December 2020

Antidepressants for smoking cessation

1 reference

12 December 2020

Anticholinergic bronchodilators in combination

1 reference

12 December 2020

Glucocorticoid-regulated transcription factors.

1 reference

12 December 2020

Neutrophil serine proteinases and defensins in chronic obstructive pulmonary disease: effects on pulmonary epithelium

1 reference

12 December 2020

Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature

1 reference

12 December 2020

Role of defensins in inflammatory lung disease

1 reference

12 December 2020

Oxidative stress and lung inflammation in airways disease.

1 reference

12 December 2020

Inhaled corticosteroids are beneficial in chronic obstructive pulmonary disease

1 reference

12 December 2020

Cilomilast, a selective phosphodiesterase-4 inhibitor for treatment of patients with chronic obstructive pulmonary disease: a randomised, dose-ranging study

1 reference

12 December 2020

Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomised trial

1 reference

12 December 2020

IFN-gamma + LPS induction of iNOS is modulated by ERK, JNK/SAPK, and p38(mapk) in a mouse macrophage cell line

1 reference

12 December 2020

Salmeterol plus theophylline combination therapy in the treatment of COPD.

1 reference

12 December 2020

Suppression of the clinical and cytokine response to endotoxin by RWJ-67657, a p38 mitogen-activated protein-kinase inhibitor, in healthy human volunteers.

1 reference

12 December 2020

Monocyte chemoattractant protein 1, interleukin 8, and chronic airways inflammation in COPD

1 reference

12 December 2020

Acupuncture for smoking cessation

1 reference

12 December 2020

Contributions of retinoids to the generation and repair of the pulmonary alveolus.

1 reference

12 December 2020

Alpha-1-antitrypsin and a broad spectrum metalloprotease inhibitor, RS113456, have similar acute anti-inflammatory effects

1 reference

12 December 2020

Neutrophil elastase and acute lung injury: prospects for sivelestat and other neutrophil elastase inhibitors as therapeutics

1 reference

12 December 2020

Oral mucolytic drugs for exacerbations of chronic obstructive pulmonary disease: systematic review

1 reference

12 December 2020

SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase

1 reference

12 December 2020

Function of PI3Kgamma in thymocyte development, T cell activation, and neutrophil migration

1 reference

12 December 2020

The Bronchitis Randomized On NAC Cost-Utility Study (BRONCUS): hypothesis and design. BRONCUS-trial Committee

1 reference

12 December 2020

Potential role of phosphodiesterase 7 in human T cell function: comparative effects of two phosphodiesterase inhibitors

1 reference

12 December 2020

Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation

1 reference

12 December 2020

Pharmacological regulation of the neuronal control of airway mucus secretion

1 reference

12 December 2020

Pharmacologic actions of the second generation leukotriene B4 receptor antagonist LY29311: in vivo pulmonary studies

1 reference

12 December 2020

Aversive smoking for smoking cessation

1 reference

12 December 2020

5-lipoxygenase inhibitors for the treatment of COPD.

1 reference

12 December 2020

Release and Activity of Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 by Alveolar Macrophages from Patients with Chronic Obstructive Pulmonary Disease

1 reference

12 December 2020

Chronic obstructive pulmonary disease

1 reference

12 December 2020

Tiotropium in the management of chronic obstructive pulmonary disease

1 reference

12 December 2020

Balance of matrix metalloprotease-9 and tissue inhibitor of metalloprotease-1 from alveolar macrophages in cigarette smokers. Regulation by interleukin-10

1 reference

12 December 2020

A vaccine for nicotine dependence: targeting the drug rather than the brain

1 reference

12 December 2020

Targeting selectins for the treatment of respiratory diseases.

1 reference

12 December 2020

Nicotinanilides as inhibitors of neutrophil chemotaxis

1 reference

12 December 2020

Nonpeptide CXCR2 antagonist prevents neutrophil accumulation in hyperoxia-exposed newborn rats.

1 reference

12 December 2020

Role of COX-2 inhibitors in the evolution of acute pain management

1 reference

12 December 2020

Sustained production of H(2)O(2) activates pro-matrix metalloproteinase-2 through receptor tyrosine kinases/phosphatidylinositol 3-kinase/NF-kappa B pathway

1 reference

12 December 2020

Effects of secretory leucocyte protease inhibitor on the production of the anti-inflammatory cytokines, IL-10 and transforming growth factor-beta (TGF-beta), by lipopolysaccharide-stimulated macrophages

1 reference

12 December 2020

Neutrophil elastase inhibitors as treatment for COPD.

1 reference

12 December 2020

Bronchial inflammation in acute bacterial exacerbations of chronic bronchitis: the role of leukotriene B4

1 reference

12 December 2020

Leukotriene B4: metabolism and signal transduction.

1 reference

12 December 2020

A pilot study of all-trans-retinoic acid for the treatment of human emphysema

1 reference

12 December 2020

Phosphodiesterases: the journey towards therapeutics

1 reference

12 December 2020

Alpha1-antitrypsin deficiency--a model for conformational diseases

1 reference

12 December 2020

Cilomilast: a second generation phosphodiesterase 4 inhibitor for asthma and chronic obstructive pulmonary disease

1 reference

12 December 2020

A Systematic Review of the Effects of Bronchodilators on Exercise Capacity in Patients With COPD

1 reference

12 December 2020

Scientific rationale for inhaled combination therapy with long-acting beta2-agonists and corticosteroids

1 reference

12 December 2020

Mechanisms in COPD: differences from asthma

1 reference

12 December 2020

Selective muscarinic receptor antagonists for airway diseases

1 reference

12 December 2020

Genetic risk factors for chronic obstructive pulmonary disease

1 reference

12 December 2020

A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease

1 reference

12 December 2020

The discovery and synthesis of highly potent, A2a receptor agonists

1 reference

12 December 2020

The green tea polyphenol (-)-epigallocatechin-3-gallate blocks nuclear factor-kappa B activation by inhibiting I kappa B kinase activity in the intestinal epithelial cell line IEC-6.

1 reference

12 December 2020

Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease. The Interleukin 10 Inflammatory Bowel Disease Cooperative Study Group

1 reference

12 December 2020

Glucose for smoking cessation: does it have a role?

1 reference

12 December 2020

Ventilator-induced lung injury upregulates and activates gelatinases and EMMPRIN: attenuation by the synthetic matrix metalloproteinase inhibitor, Prinomastat (AG3340)

1 reference

12 December 2020

COPD: epidemiology, prevalence, morbidity and mortality, and disease heterogeneity

1 reference

12 December 2020

Tobacco dependence. Global public health potential for new medications development and indications

1 reference

12 December 2020

Increased expression of the chemokine receptor CXCR3 and its ligand CXCL10 in peripheral airways of smokers with chronic obstructive pulmonary disease.

1 reference

12 December 2020

Antimuscarinic treatment for lung diseases from research to clinical practice

1 reference

12 December 2020

Remodeling in response to infection and injury. Airway inflammation and hypersecretion of mucus in smoking subjects with chronic obstructive pulmonary disease

1 reference

12 December 2020

Exhaled Carbon Monoxide and Nitric Oxide in COPD

1 reference

12 December 2020

Cytokines and therapy in COPD: a promising combination?

1 reference

12 December 2020

Cathepsin B, L, and S cleave and inactivate secretory leucoprotease inhibitor

1 reference

12 December 2020

Proteases and antiproteases

1 reference

12 December 2020

Evaluation of current pharmacotherapy of chronic obstructive pulmonary disease

1 reference

12 December 2020

The pyrrolopyrimidine U101033E is a potent free radical scavenger and prevents Fe(II)-induced lipid peroxidation in synaptosomal membranes

1 reference

12 December 2020

Preclinical development of a vaccine 'against smoking'.

1 reference

12 December 2020

The next generation of PDE4 inhibitors

1 reference

12 December 2020

All trans-retinoic acid selectively down-regulates matrix metalloproteinase-9 (MMP-9) and up-regulates tissue inhibitor of metalloproteinase-1 (TIMP-1) in human bronchoalveolar lavage cells

1 reference

12 December 2020

Impaired inhibition by dexamethasone of cytokine release by alveolar macrophages from patients with chronic obstructive pulmonary disease

1 reference

12 December 2020

Interactive roles of superoxide and inducible nitric oxide synthase in rat intestinal injury provoked by non-steroidal anti-inflammatory drugs

1 reference

12 December 2020

Inhibition of p38 MAP kinase as a therapeutic strategy

1 reference

12 December 2020

Effects of NFkappaB decoy oligonucleotides released from biodegradable polymer microparticles on a glioblastoma cell line.

1 reference

12 December 2020

Animal models of chronic obstructive pulmonary disease.

1 reference

12 December 2020

Pressurised metered-dose inhalers versus all other hand-held inhalers devices to deliver bronchodilators for chronic obstructive pulmonary disease

1 reference

12 December 2020

Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease

1 reference

12 December 2020

Comparison of the structural and inflammatory features of COPD and asthma. Giles F. Filley Lecture

1 reference

12 December 2020

Evolving concepts in the pathogenesis of chronic obstructive pulmonary disease

1 reference

12 December 2020

Bacteria, antibiotics and COPD.

1 reference

12 December 2020

In patients with COPD, treatment with a combination of formoterol and ipratropium is more effective than a combination of salbutamol and ipratropium : a 3-week, randomized, double-blind, within-patient, multicenter study

1 reference

12 December 2020

Inhibition of bleomycin-induced pulmonary fibrosis in mice by the matrix metalloproteinase inhibitor batimastat

1 reference

12 December 2020

The airway goblet cell

1 reference

12 December 2020

Interleukin-8 receptor antagonists in pulmonary diseases

1 reference

12 December 2020

Increase in reactive nitrogen species production in chronic obstructive pulmonary disease airways

1 reference

12 December 2020

Neutrophil chemotactic activity of sputum from patients with COPD: role of interleukin 8 and leukotriene B4.

1 reference

12 December 2020

Alternative mechanisms for long-acting beta(2)-adrenergic agonists in COPD.

1 reference

12 December 2020

Attenuation of bleomycin-induced pulmonary fibrosis by a catalytic antioxidant metalloporphyrin

1 reference

12 December 2020

Effects of CGS 21680, a selective adenosine A2A receptor agonist, on allergic airways inflammation in the rat.

1 reference

12 December 2020

Inhibition of human neutrophil elastase-induced acute lung injury in hamsters by recombinant human pre-elafin (trappin-2).

1 reference

12 December 2020

Nonpeptidyl mimetics of superoxide dismutase in clinical therapies for diseases

1 reference

12 December 2020

Differential roles of CC chemokine ligand 2/monocyte chemotactic protein-1 and CCR2 in the development of T1 immunity

1 reference

12 December 2020

Inhibition of tumor necrosis factor-alpha (TNF-alpha) production and arthritis in the rat by GW3333, a dual inhibitor of TNF-alpha-converting enzyme and matrix metalloproteinases

1 reference

12 December 2020

Phosphodiesterase 4 inhibitors for the treatment of COPD.

1 reference

12 December 2020

Hypnotherapy for smoking cessation.

1 reference

12 December 2020

Lymphocytes, chronic bronchitis and chronic obstructive pulmonary disease

1 reference

12 December 2020

Epidemiology of chronic obstructive pulmonary disease

1 reference

12 December 2020

Pharmacological manipulation of the inflammatory cascade by the superoxide dismutase mimetic, M40403

1 reference

12 December 2020

Alveolar macrophage-mediated elastolysis: roles of matrix metalloproteinases, cysteine, and serine proteases

1 reference

12 December 2020

Cost-effectiveness analysis of oral N-acetylcysteine as a preventive treatment in chronic bronchitis

1 reference

12 December 2020

Neutrophils and the pathogenesis of COPD.

1 reference

12 December 2020

Remodeling in asthma and chronic obstructive lung disease

1 reference

12 December 2020

New treatments for chronic obstructive pulmonary disease

1 reference

12 December 2020

Chemokine receptors: multifaceted therapeutic targets

1 reference

12 December 2020

Genetic variants of human beta-defensin-1 and chronic obstructive pulmonary disease

1 reference

12 December 2020

Increased nitrosothiols in exhaled breath condensate in inflammatory airway diseases.

1 reference

12 December 2020

Monoclonal antibodies as a strategy for pulmonary diseases

1 reference

12 December 2020

Isoprostanes: an overview and putative roles in pulmonary pathophysiology

1 reference

12 December 2020

Synthesis and P2Y receptor activity of a series of uridine dinucleoside 5'-polyphosphates

1 reference

12 December 2020

International union of pharmacology. XXII. Nomenclature for chemokine receptors

1 reference

12 December 2020

Delayed neutrophil elastase inhibition prevents subsequent progression of acute lung injury induced by endotoxin inhalation in hamsters

1 reference

12 December 2020

Antimicrobial activity of antiproteinases

1 reference

12 December 2020

Long-acting bronchodilation with once-daily dosing of tiotropium (Spiriva) in stable chronic obstructive pulmonary disease

1 reference

12 December 2020

Effect of theophylline on induced sputum inflammatory indices and neutrophil chemotaxis in chronic obstructive pulmonary disease.

1 reference

12 December 2020

Kinase regulation in inflammatory response

1 reference

12 December 2020

Human neutrophil defensins induce lung epithelial cell proliferation in vitro.

1 reference

12 December 2020

Management of dyspnea in severe chronic obstructive pulmonary disease

1 reference

12 December 2020

Inducible targeting of IL-13 to the adult lung causes matrix metalloproteinase- and cathepsin-dependent emphysema

1 reference

12 December 2020

Airway goblet-cell mucus secretion

1 reference

12 December 2020

Inhaled corticosteroids are not beneficial in chronic obstructive pulmonary disease

1 reference

12 December 2020

Protection against acute lung injury by intravenous or intratracheal pretreatment with EPI-HNE-4, a new potent neutrophil elastase inhibitor

1 reference

12 December 2020

The phosphoinositide 3-kinase pathway

1 reference

12 December 2020

P2Y(2) receptor agonists: a new class of medication targeted at improved mucociliary clearance

1 reference

12 December 2020

Macrophages and the pathogenesis of COPD.

1 reference

12 December 2020

Systemic effects in COPD.

1 reference

12 December 2020

Enhanced neutrophil response in chronic obstructive pulmonary disease

1 reference

12 December 2020

Adenoviral E1A primes alveolar epithelial cells to PM(10)-induced transcription of interleukin-8.

1 reference

12 December 2020

SB 239063, a p38 MAPK inhibitor, reduces neutrophilia, inflammatory cytokines, MMP-9, and fibrosis in lung

1 reference

12 December 2020

Lipid inflammatory mediators: leukotrienes, prostaglandins, platelet-activating factor.

1 reference

12 December 2020

Inhibition of adhesion of human neutrophils and eosinophils to P-selectin by the sialyl Lewis antagonist TBC1269: preferential activity against neutrophil adhesion in vitro

1 reference

12 December 2020

Inhaled salmeterol: a review of its efficacy in chronic obstructive pulmonary disease

1 reference

12 December 2020

Additive effects of salmeterol and fluticasone or theophylline in COPD

1 reference

12 December 2020

The role of nuclear factor-kappa B activation in airway inflammation following adenovirus infection and COPD.

1 reference

12 December 2020

Identification of the binding site for a novel class of CCR2b chemokine receptor antagonists: binding to a common chemokine receptor motif within the helical bundle

1 reference

12 December 2020

Missing pieces in the NF-kappaB puzzle

1 reference

12 December 2020

Treating tobacco use and dependence: an evidence-based clinical practice guideline for tobacco cessation

1 reference

12 December 2020

Novel therapy for COPD.

1 reference

12 December 2020

Mucoactive drugs for asthma and COPD: any place in therapy?

1 reference

12 December 2020

Seretide for obstructive lung disease

1 reference

12 December 2020

Design of selective and soluble inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).

1 reference

12 December 2020

Efficacy of oral long-term N-acetylcysteine in chronic bronchopulmonary disease: a meta-analysis of published double-blind, placebo-controlled clinical trials

1 reference

12 December 2020

Bronchodilator therapy in chronic obstructive pulmonary disease

1 reference

12 December 2020

Mucus pathophysiology in COPD: differences to asthma, and pharmacotherapy

1 reference

12 December 2020

Exhaled markers of pulmonary disease

1 reference

12 December 2020

Inflammation of the airways and lung parenchyma in COPD: role of T cells

1 reference

12 December 2020

Thienopyridines: nitric oxide synthase inhibitors with potent in vivo activity

1 reference

12 December 2020

A metalloporphyrin-based superoxide dismutase mimic inhibits adoptive transfer of autoimmune diabetes by a diabetogenic T-cell clone

1 reference

12 December 2020

Long-term administration of N-acetylcysteine decreases hydrogen peroxide exhalation in subjects with chronic obstructive pulmonary disease

1 reference

12 December 2020

pH in expired breath condensate of patients with inflammatory airway diseases

1 reference

12 December 2020

Human collagenase (matrix metalloproteinase-1) expression in the lungs of patients with emphysema

1 reference

12 December 2020

Tachykinin receptor antagonists: potential in airways diseases

1 reference

12 December 2020

Conformationally restricted indolopiperidine derivatives as potent CCR2B receptor antagonists

1 reference

12 December 2020

Increased levels of the chemokines GROalpha and MCP-1 in sputum samples from patients with COPD.

1 reference

12 December 2020

Elastase-released Epidermal Growth Factor Recruits Epidermal Growth Factor Receptor and Extracellular Signal-regulated Kinases to Down-regulate Tropoelastin mRNA in Lung Fibroblasts

1 reference

12 December 2020